Pharma Journalist -

As scientific researchers continue to investigate the complexities of the skin microbiome, our mission for the 2nd Microbiome Movement – Skin Health & Dermatology Summit is simple:…
Read More...

SMi Reports: Registration is now open for the Inaugural Respiratory Drug Delivery conference taking place in London on 13th-14th November 2019. SMi are pleased to announce that…
Read More...

AstraZeneca has presented three-year overall survival (OS) results from the Phase III PACIFIC trial of Imfinzi (durvalumab) in unresectable, Stage III non-small cell lung cancer (NSCLC)…
Read More...

Biocartis Group NV, an innovative molecular diagnostics company (Euronext Brussels: BCART), announced that it has entered into a Master Development and Commercialization Agreement with…
Read More...

SMi Reports: SMi Group are delighted to announce that registration is open for the 5th Annual Lyophilization USA conference, taking place October 23rd-24th in Boston. Despite being a…
Read More...

SMi Reports: Novartis, SKAN and Taro Pharmaceuticals to speak on containment and banding strategies at the inaugural HPAPI USA conference, taking place on October 21st-22nd in Boston…
Read More...

Boehringer Ingelheim and Gubra announce a second collaboration and license agreement for the development of novel poly-agonist peptides to treat obesity. It will bring together Gubra’s…
Read More...

Particle Sciences, a Lubrizol LifeSciences company and pharmaceutical contract development and manufacturing organization (CDMO), has broadened its Drug Enforcement Administration (DEA)…
Read More...

Merz, a global leader in neurotoxin therapy, announced the European approval of Xeomin (incobotulinumtoxinA) for the symptomatic treatment of chronic sialorrhea (drooling) due to…
Read More...

Bayer AG and Foundation Medicine, Inc. announced a global collaboration for the development and commercialization of NGS-based companion diagnostics.  This agreement allows for…
Read More...